DPA Omega-3: A Key Fatty Acid for Heart & Brain Health

What Is DPA?

DPA, short for docosapentaenoic acid (22:5n-3), is a long-chain omega-3 polyunsaturated fatty acid that sits between EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in the body's fatty acid metabolic pathway. It is one of the three major marine-derived omega-3 fatty acids measured in comprehensive blood panels, though it gets considerably less clinical attention than EPA or DHA despite having distinct biological effects.

The body obtains DPA primarily from fatty fish and seafood. It is also present in meaningful amounts in red meat, particularly from grass-fed or pasture-raised animals. Once ingested, DPA is incorporated into cell membranes throughout the body, where it influences membrane fluidity, receptor function, and the production of signaling molecules that regulate inflammation and immune responses. Kaur et al., 2011 reviewed DPA's biological activity separately from EPA and DHA, including its capacity to inhibit platelet aggregation and reduce inflammatory signaling.

DPA occupies a metabolically active position in the omega-3 pathway. The body can convert EPA to DPA through elongation, and DPA can then be further desaturated and shortened to produce DHA. DPA can also be retroconverted back to EPA. This bidirectional flexibility gives DPA a reservoir-like role - something the body can draw on when EPA or DHA supplies run low, and which can replenish EPA levels after dietary intake or supplementation.

Beyond its metabolic role, DPA has direct biological effects. It has anti-inflammatory, anti-thrombotic, and potentially anti-angiogenic properties. Its anti-angiogenic activity - inhibiting the excessive formation of new blood vessels - has drawn interest in tumor biology and atherosclerosis, where abnormal vessel growth is part of the disease process. DPA also reduces triglyceride synthesis in the liver and modulates the expression of genes involved in fatty acid oxidation.

In blood testing, DPA is typically measured as part of an omega-3 fatty acid panel, either in plasma phospholipids or red blood cell membranes. Red blood cell measurements are generally preferred because they reflect tissue-level fatty acid status over the prior two to three months, rather than the more transient signal captured in plasma after a recent meal.

Normal Reference Range

Reference ranges for DPA are not as uniformly standardized as those for more commonly tested biomarkers like cholesterol or glucose. Most clinical laboratories report DPA as a percentage of total fatty acids in the sample - typically plasma phospholipids or red blood cell membranes. In healthy adults with moderate seafood consumption, DPA n-3 typically falls between 1.5% and 4.0% of total fatty acids when measured in plasma phospholipids. Red blood cell measurements tend to run slightly lower, generally in the range of 1.0% to 3.5%.

DPA reference ranges are not strongly age- or sex-dependent in the way that hormonal biomarkers are, though dietary patterns across demographic groups do influence population-level distributions. People who eat fatty fish two or more times per week, or who supplement regularly with fish oil, often fall toward the higher end of the normal range. Those following plant-based diets or eating little seafood typically cluster at the lower end. Some specialty labs also report absolute concentrations in micromoles per liter, but percentage-of-total-fatty-acids is the more widely used and clinically interpretable format.

Because DPA is almost always assessed alongside the full omega-3 panel - including EPA, DHA, and sometimes alpha-linolenic acid - it is most meaningful when interpreted in that context. A low DPA result accompanied by adequate EPA and DHA carries different clinical weight than a pattern of across-the-board omega-3 depletion. Your clinician can interpret your DPA value within that broader picture.

What High DPA Levels Mean

Elevated DPA most commonly reflects high omega-3 intake - from dietary sources, supplementation, or both. People who eat fatty fish several times per week or take larger doses of marine-derived omega-3 supplements reliably show higher DPA concentrations. In that context, higher DPA is generally not a problem and tends to accompany favorable cardiovascular and inflammatory profiles. Mozaffarian and Wu, 2011 summarized evidence linking higher tissue concentrations of long-chain omega-3 fatty acids - including DPA - with reduced cardiovascular event risk and improved lipid profiles.

A less obvious cause of elevated DPA is impaired conversion of DPA to DHA downstream in the metabolic pathway. Certain genetic variants - particularly in the FADS1 and FADS2 genes, which encode the desaturase enzymes responsible for fatty acid elongation and desaturation - can slow the conversion of DPA to DHA. In individuals with these variants, DPA may accumulate at higher-than-expected levels even without extraordinary dietary intake. This pattern sometimes presents as elevated DPA alongside lower-than-expected DHA, and identifying it can inform decisions about which type of omega-3 supplementation will be most effective.

Conditions associated with high DPA include:

• Regular consumption of fatty fish (salmon, mackerel, herring, sardines) or seal oil products

• High-dose omega-3 supplementation (fish oil, krill oil)

• Reduced downstream FADS2 enzyme activity due to genetic variation

• Grass-fed red meat consumption (a meaningful dietary DPA source)

• Certain metabolic adaptations in populations with historically high marine-food diets

Very high DPA from supplementation is worth discussing with your clinician primarily in the context of blood-thinning effects, since omega-3 fatty acids reduce platelet aggregation and can modestly prolong bleeding time at high doses - a practical concern before surgical procedures. Otherwise, dietary DPA elevation is rarely a clinical problem and typically reflects favorable lifestyle patterns.

What Low DPA Levels Mean

Low DPA most commonly reflects insufficient dietary intake of marine-derived omega-3 fatty acids. Individuals who eat little or no seafood and do not supplement are at highest risk. This includes many people following vegetarian or vegan diets, those with seafood allergies, and those in regions or economic circumstances where fatty fish is not a dietary staple. Plant-based omega-3 sources provide ALA, which the body converts to long-chain forms like DPA only very inefficiently, so low intake tends to translate directly to low tissue concentrations.

Low DPA can also result from conditions that impair fat absorption. Gastrointestinal diseases including Crohn's disease, celiac disease, and conditions that damage the small intestinal lining reduce absorption of dietary fats, including omega-3 fatty acids. Pancreatic insufficiency, which impairs fat digestion, has a similar effect. Chronic alcohol use can also impair omega-3 metabolism and incorporation. High systemic inflammation may increase the utilization of DPA and other omega-3 fatty acids as precursors to anti-inflammatory mediators, potentially depleting circulating levels even when dietary intake is adequate.

Symptoms to watch for when DPA and broader omega-3 levels are low include:

• Dry or flaky skin and brittle hair or nails

• Joint stiffness or elevated markers of systemic inflammation

• Difficulty concentrating or low mood, given omega-3's role in neurological function

• Elevated triglycerides on a lipid panel, which omega-3 fatty acids help regulate

• Slower-than-expected recovery from inflammatory conditions or injury

Low DPA should be interpreted alongside the full omega-3 panel. When EPA and DHA are also low, the picture points clearly to inadequate omega-3 status overall. When DPA alone is low but EPA is near normal, it may suggest a bottleneck in the elongation step that converts EPA to DPA - less common, but worth flagging to your clinician.

How to Optimize Your DPA Naturally

The most direct way to raise DPA is to increase consumption of marine-derived omega-3 sources. Fatty fish - salmon, mackerel, sardines, herring, and anchovies - are the richest dietary sources. Two to three servings per week can meaningfully shift DPA levels within two to three months of consistent intake. Among marine sources, seal oil is particularly high in DPA relative to EPA and DHA, though it is not widely available commercially. Grass-fed beef contains more DPA than grain-fed beef and serves as a supplemental source for those who eat red meat. For a detailed breakdown of evidence-based approaches, see the how to improve your DPA naturally guide.

Omega-3 supplements are an effective and practical option for those who do not consume adequate seafood. Standard fish oil supplements contain EPA and DHA, with DPA in smaller amounts. Since DPA is synthesized from EPA in the body, raising EPA intake through supplementation will generally support DPA production. Krill oil contains similar omega-3 profiles and may have better bioavailability for some people due to its phospholipid-bound fatty acid structure. Algal oil, derived from microalgae, provides DHA and some EPA and is the preferred option for those following plant-based diets, though its DPA content is typically lower than fish-derived sources.

Dietary context shapes how well the body metabolizes omega-3s. A diet high in omega-6 polyunsaturated fatty acids - found in refined vegetable oils like corn, sunflower, and soybean oil - competes with omega-3 metabolism because both pathways share the same elongase and desaturase enzymes. Reducing processed food intake and replacing refined seed oils with olive oil or avocado oil reduces this competition and allows more efficient omega-3 metabolism, including DPA. Limiting trans fats, which directly impair delta-6 desaturase activity, supports the same pathway. Calder, 2017 provides an accessible overview of how dietary fat composition shapes omega-3 metabolism at the molecular level.

There is no standalone DPA supplement on the market yet, though research into concentrated marine lipid fractions is ongoing. For now, increasing EPA through dietary or supplemental means remains the most reliable way to support DPA levels, given the metabolic relationship between the two. If genetic variants in FADS genes are suspected, pre-formed DHA supplementation may be more directly useful than EPA-heavy products, since it bypasses the conversion steps where enzyme activity is reduced.

Testing and Monitoring

DPA is measured through a blood draw and analyzed as part of a comprehensive fatty acid or omega-3 panel. Most labs use plasma or red blood cells as the sample matrix. Fasting is generally not required, though some labs prefer a four-hour fast to reduce the acute influence of a recent meal on plasma fatty acid levels. Red blood cell fatty acid analysis is unaffected by recent meals and is often considered the more reliable measure of long-term dietary fatty acid status, reflecting intake over the preceding two to three months.

If your DPA is low and you are making dietary or supplemental changes, retesting after three to four months allows enough time for cell membrane fatty acid composition to shift meaningfully. Plasma concentrations can respond somewhat sooner - within four to six weeks - but red blood cell levels take longer. Retesting too soon after a change may not capture the full effect of the intervention.

Mito Health's comprehensive panel ($349 for individuals, $668 for duos) includes omega-3 fatty acid analysis alongside over 100 biomarkers spanning metabolic health, inflammation, cardiovascular risk, hormones, and nutritional status. Testing DPA in isolation provides limited value; understanding it alongside your full omega-3 profile, lipid panel, and inflammatory markers gives a far more complete and actionable picture of your health.

Frequently Asked Questions

Q: Is DPA the same as DHA?

A: No. DPA (22:5n-3) and DHA (22:6n-3) are distinct omega-3 fatty acids, though closely related. DPA is a metabolic precursor to DHA - the body converts DPA into DHA through a desaturation step. DHA is more concentrated in the brain and retina, while DPA is found throughout cell membranes and has its own anti-inflammatory and anti-thrombotic properties. Both appear on comprehensive omega-3 panels, and both matter for cardiovascular and neurological health.

Q: Can I raise my DPA through plant-based sources alone?

A: Practically speaking, it is difficult. Plant-based omega-3 sources provide alpha-linolenic acid (ALA), found in flaxseed, chia, walnuts, and hemp. The body converts ALA to EPA and then to DPA, but conversion efficiency is low - typically under 5% to 10% for EPA and even less for DPA and DHA. People following plant-based diets who want to maintain their omega-3 status, including DPA, generally benefit from algal oil supplementation, which provides pre-formed DHA and some EPA and bypasses the inefficient conversion steps.

Q: My DPA is low but my EPA and DHA look normal. What does that mean?

A: This pattern is less common but can occur. It may suggest a relative inefficiency in the elongase enzyme that converts EPA to DPA - the first step in the pathway between the two. It can also reflect the specific types and ratios of omega-3 sources you consume, since some fish oil products have particularly high EPA-to-DPA ratios. Your clinician can help interpret this alongside your full panel and dietary history.

Q: Does a high DPA result mean I am taking too much fish oil?

A: Not automatically. Elevated DPA in the context of regular fish consumption or supplementation is generally benign. The main clinical consideration at very high omega-3 doses - typically above 3 to 4 grams of EPA plus DHA per day - is the blood-thinning effect, which can be relevant before surgery or for individuals on anticoagulant medications. If your DPA is elevated and you take high-dose fish oil, it is worth discussing your supplement regimen with your physician, but elevated DPA alone is not a reason for alarm.